GSTM1 and sickle cell disease: Anemia and hemoglobin variant testing together have also become possible due to the system described by An et al. [19], which assembled a system capable of both quantifying the Hb concentration in blood and discriminating between different forms of Hb to identify patients having genetic variants that may lead to sickle cell disease.